This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BLADDER_EXALLC for full statistics.
Malignant neoplasm of bladder
C3_BLADDER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2855 |
4. Check minimum number of eventsNone |
2855 |
5. Include endpointsNone |
2855 |
6. Filter based on genotype QC (FinnGen only) |
2855 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bladder
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2855 | 456 | 2399 |
| Unadjusted period prevalence (%) | 0.91 | 0.16 | 1.06 |
| Median age at first event (years) | 70.64 | 67.99 | 71.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2683
- Matched controls
- 26828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
224.7
323.0
418
22
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
264.2
323.0
1716
179
R31
ICD-10 Finland
Unspecified haematuria
9.7
323.0
1311
2414
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
12869.3
323.0
2064
5
KCD02
NOMESCO Finland
Transurethral resection of bladder
342.1
323.0
2008
233
UKC02
NOMESCO Finland
Cystoscopy
38.2
323.0
2332
3973
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
297.3
323.0
1440
104
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
73.1
323.0
980
209
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
82.5
323.0
671
108
KCC10
NOMESCO Finland
Cystoprostatectomy
342.5
323.0
406
14
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
154.9
323.0
782
71
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
58.0
323.0
502
106
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
290.6
308.2
309
12
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
32.6
288.1
385
137
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
116.8
279.8
301
29
ZX136
NOMESCO Finland
Intravesicalis
54.7
267.0
319
66
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
216.6
205
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
416.9
196.7
195
5
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
146.2
192.3
203
15
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
25.1
184.3
264
116
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
820.0
159.2
155
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
26.5
159.0
224
92
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
402.1
153.8
153
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
104.0
152.0
166
17
J01MA02
ATC
ciprofloxacin; systemic
2.9
151.4
1518
8234
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.7
149.7
473
966
KCB00
NOMESCO Finland
Biopsy of bladder
73.0
144.6
165
24
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
11.8
143.1
275
257
7323
FHL
Electrosection of TU bladder wall change
187.2
136.9
142
8
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
14.7
135.7
235
174
J01EA01
ATC
trimethoprim; systemic
3.2
131.3
892
3631
U76
ICPC
Malignant neoplasm of bladder
110.9
126.3
137
13
130
Kela drug reimbursment
Malignant tumour
4.0
123.1
572
1712
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
122.6
704
2510
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
1210.1
119.7
116
*
KCW96
NOMESCO Finland
Other operations on bladder
29.0
110.3
151
55
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
20.0
110.2
169
90
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
1058.1
105.0
102
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.3
103.0
617
2233
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
99.9
496
1546
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
26.1
98.8
139
56
8120/3-C67.2
ICD-O-3
Transitional cell carcinoma, NOS, of lateral wall of bladder
993.4
98.7
96
*
WX320
NOMESCO Finland
Spinalanesthesy
2.7
96.4
827
3772
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.4
96.3
222
285
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
93.8
875
4178
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
17.7
91.4
146
87
7321
FHL
TU biopsy, coagulation or laser
34.9
87.5
114
34
U06
ICPC
Haematuria
6.7
84.3
227
366
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
8.1
83.6
197
261
TJF80
NOMESCO Finland
Ostomy education
16.6
83.2
136
86
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
28.3
79.4
109
40
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
38.5
73.0
93
25
XKD00
NOMESCO Finland
Uroflowmetry
2.3
71.4
890
4794
KA3EB
NOMESCO Finland
Antegrade pyelography
27.1
70.0
97
37
A04AD12
ATC
aprepitant; systemic
12.3
69.0
128
109
B02AA02
ATC
tranexamic acid; systemic
3.4
68.4
366
1185
JN4AD
NOMESCO Finland
Body CT examination
3.5
68.3
359
1147
KCD30
NOMESCO Finland
Destruction of tumour of bladder
124.9
68.2
73
6
JN4BD
NOMESCO Finland
Extensive body CT
2.9
67.4
473
1851
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
64.7
642
3063
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.0
64.1
278
754
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
200.9
57.2
59
*
JEA00
NOMESCO Finland
Appendectomy
4.4
56.6
218
528
B01AB10
ATC
tinzaparin; parenteral
3.6
55.9
273
817
KA1FN
NOMESCO Finland
Isotope renography
18.3
55.6
87
49
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
55.5
668
3465
KC1GB
NOMESCO Finland
Cystography with X-ray
10.5
54.6
109
108
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
54.4
217
543
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
145.4
54.0
57
*
KDV10
NOMESCO Finland
Internal urethrotomy
6.2
53.1
149
252
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
98.7
53.0
58
6
1530
FHL
Urethrocystoscopy
4.8
51.2
181
401
J01MA12
ATC
levofloxacin; systemic
2.1
51.2
700
3820
H02AB02
ATC
dexamethasone; systemic
2.9
51.1
350
1332
UKB02
NOMESCO Finland
Retrograde ureteroscopy
9.0
50.4
109
125
8000/3-C67.9
ICD-O-3
Neoplasm, malignant of bladder, NOS
+∞
50.1
48
*
A04AA02
ATC
granisetron; systemic, transdermal
3.8
49.8
226
634
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.2
49.4
138
232
KH1AD
NOMESCO Finland
CT of urinary organs
5.0
49.1
164
342
1889X
ICD-9 Finland
Malignant neoplasm of bladder, Bladder, part unspecified
132.4
48.9
52
*
N30.0
ICD-10 Finland
Acute cystitis
2.7
48.8
382
1572
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
45.7
429
1948
C66
ICD-10 Finland
Malignant neoplasm of ureter
26.8
45.6
63
24
J01CA08
ATC
pivmecillinam; oral
2.1
44.6
595
3186
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
8.1
44.6
103
132
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
63.6
43.3
50
8
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
18.8
42.8
66
36
Z51.5
ICD-10 Finland
Palliative care
2.8
42.2
294
1124
R33
ICD-10 Finland
Retention of urine
2.3
42.1
468
2301
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
40.7
274
1023
ZXC20
NOMESCO Finland
Use of chemical agents
4.5
39.0
144
333
XKD10
NOMESCO Finland
Transurethral ultrasonography
74.6
39.0
44
6
B01AB05
ATC
enoxaparin; parenteral
1.8
38.7
837
5329
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
38.4
198
614
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.7
38.3
178
508
18899
ICD-8 Finland
Malignant neoplasm of bladder
104.0
37.8
41
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
20.4
37.5
56
28
WX224
NOMESCO Finland
Blockade of obturius nerve
55.8
37.4
44
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.6
37.1
177
516
KCC00
NOMESCO Finland
Cystectomy
372.2
37.1
37
*
4CX01
NOMESCO Finland
NA
70.9
37.0
42
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
36.9
472
2459
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
35.5
1220
8891
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
18.1
35.4
55
31
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
182.3
34.8
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
34.4
736
4635
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
34.1
329
1503
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
177.1
33.8
35
*
N02AA05
ATC
oxycodone; systemic
1.9
32.6
532
3037
N30.9
ICD-10 Finland
Cystitis, unspecified
3.1
32.6
185
616
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
14.9
32.3
54
37
SPAT1125
SPAT
Stoma care and guidance
4.8
31.2
106
226
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
30.9
360
1789
KBV00
NOMESCO Finland
Insertion of stent into ureter
11.6
30.6
57
50
WZC30
NOMESCO Finland
Teaching
2.2
30.0
352
1754
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.6
29.9
141
408
A04AA01
ATC
ondansetron; systemic, rectal
2.9
29.5
186
664
A04AA55
ATC
palonosetron, combinations; systemic
6.7
29.2
76
117
8120/3-C67.4
ICD-O-3
Transitional cell carcinoma, NOS, of posterior wall of bladder
+∞
29.2
28
*
8120/3-C67.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of bladder
+∞
29.2
28
*
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
19.4
29.1
44
23
U99
ICPC
Urinary disease other
7.8
28.7
67
88
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
151.5
28.7
30
*
WX402
NOMESCO Finland
General anaesthesia
2.1
28.4
339
1699
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
7.3
28.0
68
95
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
27.5
28.0
38
14
N02BE01
ATC
paracetamol; systemic, rectal
1.7
27.7
2041
17636
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
27.7
418
2305
J01DB01
ATC
cefalexin; oral
1.6
27.5
1858
15668
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.2
27.1
150
491
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
12.9
26.6
47
37
WF004
NOMESCO Finland
Palliative radiotherapy
4.2
25.8
101
249
KAC20
NOMESCO Finland
Nephroureterectomy
17.6
25.7
40
23
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
94.3
25.7
28
*
SPAT1262
SPAT
Handing over of treatment supplies
1.8
25.7
545
3374
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
22.0
25.6
37
17
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.6
25.6
121
351
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.3
25.5
133
417
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.9
25.1
107
285
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
25.0
24
*
WX882
NOMESCO Finland
High dependency care
3.4
25.0
126
385
C67.7
ICD-10 Finland
Malignant neoplasm: Urachus
131.2
24.6
26
*
KED22
NOMESCO Finland
Transurethral resection of prostate
1.9
23.1
355
1960
U07
ICPC
Urine symptom/complaint other
2.6
23.0
179
726
UKD02
NOMESCO Finland
Urethroscopy
8.0
22.9
52
66
U28
ICPC
Limited function/disability (U)
5.0
22.7
74
152
J01MA01
ATC
ofloxacin; systemic
2.0
22.2
308
1636
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
80.7
21.7
24
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.8
21.3
91
244
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
20.9
268
1377
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
20.9
555
3647
8120/3-C67.6
ICD-O-3
Transitional cell carcinoma, NOS, of ureteric orifice
+∞
20.9
20
*
3AX03
NOMESCO Finland
NA
211.4
20.6
21
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
20.3
195
880
G04CA02
ATC
tamsulosin; oral
1.5
19.8
1100
8586
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.6
19.5
88
247
KH1CB
NOMESCO Finland
Urography with X-ray
24.8
19.5
27
11
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.5
19.3
50
78
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.0
19.2
78
200
U29
ICPC
Urinary symptom/complaint other
3.3
19.2
99
309
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.4
19.0
45
62
8120/3-C67.1
ICD-O-3
Transitional cell carcinoma, NOS, of dome of bladder
+∞
18.8
18
*
8120/3-C67.5
ICD-O-3
Transitional cell carcinoma, NOS, of bladder neck
+∞
18.8
18
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
10.7
17.9
34
32
KBH20
NOMESCO Finland
Replantation of ureter
26.9
17.8
24
9
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.6
17.5
497
3304
KA3GB
NOMESCO Finland
Retrograde pyelography
21.0
17.3
25
12
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.6
17.2
481
3182
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
3.1
17.1
94
309
G04BD08
ATC
solifenacin; oral
2.0
17.0
214
1092
J01MA06
ATC
norfloxacin; oral
1.8
16.9
309
1806
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
9.5
16.9
34
36
7343
FHL
Cystectomy and enterocystoplasty
+∞
16.7
16
*
UKC22
NOMESCO Finland
Urethroneocystoscopy
+∞
16.7
16
*
KBD00
NOMESCO Finland
Partial excision of ureter
35.2
16.7
21
6
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
90.6
16.6
18
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.8
16.4
69
184
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
3.7
16.3
72
200
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
16.2
613
4363
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
47.8
16.0
19
*
U05
ICPC
Urination problems other
2.2
15.7
158
732
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
7.9
15.6
35
45
Z93
ICD-10 Finland
Artificial opening status
11.8
15.5
28
24
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
16.1
15.2
24
15
KWW96
NOMESCO Finland
Other reoperation in urological surgery
45.2
15.1
18
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.1
14.9
58
145
SPAT1167
SPAT
Insertion of urinary catheter
2.2
14.8
146
669
KCJ10
NOMESCO Finland
Cutaneous cystoenterostomy
+∞
14.6
14
*
KCH10
NOMESCO Finland
Enterocystoplasty
+∞
14.6
14
*
U70
ICPC
Pyelonephritis/pyelitis
5.0
14.6
46
93
U13
ICPC
Bladder symptom/complaint other
3.0
14.5
83
279
U14
ICPC
Kidney symptom/complaint
3.9
14.4
59
154
4078
NOMESCO Finland
NA
53.6
13.8
16
*
1880A
ICD-9 Finland
Malignant neoplasm of bladder, Trigone of urinary bladder
+∞
13.5
13
*
KDC00
NOMESCO Finland
Urethrectomy
140.6
13.5
14
*
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
140.6
13.5
14
*
KBV10
NOMESCO Finland
Removal of stent from ureter
5.7
13.1
37
66
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
13.1
118
519
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.3
13.1
121
540
J01CA04
ATC
amoxicillin; systemic
1.4
12.9
1657
14568
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
70.2
12.6
14
*
2394A
ICD-9 Finland
Neoplasm of unspecified nature, Bladder
32.2
12.6
16
5
N02AX02
ATC
tramadol; systemic, rectal
1.4
12.5
1004
8172
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
6.1
12.4
33
55
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.2
12.3
64
204
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
12.3
251
1515
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
15.9
12.1
19
12
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
12.1
72
252
G04BD12
ATC
mirabegron; oral
1.7
12.1
267
1649
7326
FHL
Bladder lavage
11.1
12.0
22
20
KCD10
NOMESCO Finland
Partial cystectomy
21.4
12.0
17
8
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.0
11.7
67
227
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
11.7
167
896
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.1
11.6
61
197
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
11.5
118
551
8140/3-C67.9
ICD-O-3
Adenocarcinoma, NOS, of bladder, NOS
+∞
11.5
11
*
A06AH03
ATC
naloxegol; oral
4.1
11.4
43
106
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.3
921
7481
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
11.3
144
739
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.4
11.3
90
375
7339
FHL
Other measure in this category
25.1
11.1
15
6
A41.8
ICD-10 Finland
Other specified sepsis
2.9
11.1
66
232
R50.9
ICD-10 Finland
Fever, unspecified
1.5
10.9
342
2311
SPAT1168
SPAT
Catheterisation training
5.0
10.9
34
69
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
60.2
10.6
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.5
10.6
81
329
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
11.2
10.5
19
17
U77
ICPC
Malignant neopl urinary tract other
6.5
10.5
26
40
N02
ICD-10 Finland
Recurrent and persistent haematuria
14.2
10.5
17
12
KDW98
NOMESCO Finland
Other transluminal endoscopic operations on urethra
110.4
10.4
11
*
8041/3-C67.9
ICD-O-3
Small cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
Z93.5
ICD-10 Finland
Cystostomy status
7.7
10.4
23
30
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
10.3
445
3223
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.5
10.3
46
132
U02
ICPC
Urinary frequency/urgency
1.7
10.3
214
1300
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.2
235
1470
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.4
10.2
85
361
KH1DD
NOMESCO Finland
CT urography of urinary organs
13.1
10.1
17
13
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
9.1
10.0
20
22
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.0
10.0
38
95
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.4
10.0
443
3224
JAH00
NOMESCO Finland
Laparotomy
2.3
9.9
87
382
WW500
NOMESCO Finland
Blood transfusion
2.1
9.8
113
558
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
26.1
9.8
13
5
N21.0
ICD-10 Finland
Calculus in bladder
3.0
9.8
54
182
U71
ICPC
Cystitis/urinary infection other
2.2
9.6
92
419
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.6
9.5
66
256
U04
ICPC
Incontinence urine
2.0
9.4
113
570
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
30.1
9.4
12
*
1544
FHL
Urinary tract endoscopy
17.6
9.4
14
8
8120/3-C67.0
ICD-O-3
Transitional cell carcinoma, NOS, of trigone of bladder
+∞
9.4
9
*
U79
ICPC
Neoplasm urinary tract unspecified
13.7
9.2
15
11
R4110
NOMESCO Finland
Physiotherapy
1.4
9.1
562
4335
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
8.9
653
5179
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.9
186
1130
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
8.5
103
521
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
27.6
8.5
11
*
G04BE01
ATC
alprostadil; parenteral, urethral
2.1
8.4
92
447
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
12.8
8.4
14
11
N07BA03
ATC
varenicline; oral
2.4
8.3
65
270
8010/3-C67.9
ICD-O-3
Carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
KBJ00
NOMESCO Finland
Cutaneous ureterostomy
+∞
8.3
8
*
7342
FHL
Cystectomy and differential surgery
+∞
8.3
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
8.3
122
665
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
8.3
130
726
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
14.5
8.2
13
9
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.4
8.1
67
288
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
13.0
7.9
13
10
TKC00
NOMESCO Finland
Needle biopsy of bladder
13.0
7.9
13
10
WX704
NOMESCO Finland
Intubation
1.8
7.8
135
778
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.8
188
1191
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.9
7.7
45
158
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
7.7
69
307
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.2
7.6
76
355
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.8
7.6
45
161
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
7.6
221
1469
V03AE01
ATC
polystyrene sulfonate; oral
2.7
7.5
48
177
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
80.3
7.4
8
*
A28
ICPC
Limited function/disability NOS
1.4
7.3
458
3536
8070/3-C67.9
ICD-O-3
Squamous cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
8130/3-C67.2
ICD-O-3
Papillary urothelial carcinoma of lateral wall of bladder
+∞
7.3
7
*
L03AA02
ATC
filgrastim; parenteral
2.3
7.3
66
296
WX110
NOMESCO Finland
Local anesthesy
1.2
7.2
1200
10547
G04AC01
ATC
NA
2.3
7.1
63
281
R03BB04
ATC
tiotropium bromide; inhalant
1.4
7.1
332
2440
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.9
7.0
27
70
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.2
7.0
67
308
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.3
7.0
24
56
U01
ICPC
Dysuria/painful urination
1.9
6.9
90
472
N30.8
ICD-10 Finland
Other cystitis
5.5
6.9
19
35
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
6.9
299
2162
KBB00
NOMESCO Finland
Biopsy of ureter
13.8
6.9
11
8
J01XE01
ATC
nitrofurantoin; oral
2.8
6.9
42
154
G04CA01
ATC
alfuzosin; oral
1.4
6.9
436
3368
KC1GD
NOMESCO Finland
CT cystography of bladder
40.1
6.8
8
*
KBH96
NOMESCO Finland
Other repair or connection of ureter
40.1
6.8
8
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
22.6
6.7
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
6.7
241
1680
KGH10
NOMESCO Finland
Operation for phimosis
2.0
6.7
81
414
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.9
6.7
93
498
A03
ICPC
Fever
1.5
6.6
199
1335
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.2
6.6
60
272
E87.5
ICD-10 Finland
Hyperkalaemia
2.3
6.5
58
260
Z72.0
ICD-10 Finland
Tobacco use
2.6
6.5
43
166
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
2.3
6.5
53
229
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.9
6.4
35
120
RD211
NOMESCO Finland
NA
1.9
6.4
83
435
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.5
6.4
184
1220
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
6.4
150
945
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
6.5
6.3
15
23
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
6.5
6.3
15
23
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
8.2
6.3
13
16
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.3
409
3169
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
18.0
6.3
9
5
KBC00
NOMESCO Finland
Ureterectomy
+∞
6.2
6
*
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
5.3
6.1
17
32
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
6.1
104
599
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.1
249
1780
JF1AD
NOMESCO Finland
Small bowel CT
4.9
6.0
18
37
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
2.7
6.0
39
147
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1574
8440
2.93
170.87
8.7
3.5
—
—
—
0
0
717
3134
2.72
105.81
8.1
6.5
105.5
104.4
mmol/l
8.61
711
3039
1000
5156
2.45
104.11
5.8
2.7
5.1
3.6
e6/l
3.09
933
4570
1249
7208
2.30
99.21
9.5
3.5
277.8
123.2
e6/l
1.90
1114
5797
1931
13647
2.28
89.87
12.4
4.8
1634.7
1852.8
e6/l
0.06
34
297
1304
7927
2.19
88.27
10.3
3.9
295.4
101.4
e6/l
2.57
1154
6095
1104
6450
2.16
80.89
9.5
3.4
0.5
0.5
e6/l
0.47
987
5066
1441
9373
2.08
78.86
5.8
4.5
—
—
—
0
0
729
3738
2.28
72.61
9.1
3.2
1.0
1.3
e6/l
1.67
574
2215
748
3903
2.24
71.23
8.3
3.0
2.1
1.1
e6/l
4.93
589
2355
410
1704
2.64
64.24
5.3
3.7
0.2
1.9
mmol/l
12.03
314
1207
422
1792
2.59
63.23
5.5
3.8
5.0
5.1
kpa
3.58
404
1625
516
2477
2.32
58.78
5.1
3.6
5.9
5.8
kpa
1.72
505
2386
513
2474
2.31
57.72
5.1
3.6
1.4
1.9
mmol/l
1.99
443
1925
275
1031
2.84
52.21
5.9
4.3
23.9
24.6
mmol/l
4.04
261
929
835
5074
1.91
49.66
3.2
2.6
—
—
—
0
0
652
3693
1.99
47.42
4.8
3.0
0.8
0.8
mmol/l
4.93
612
3415
433
2225
2.11
40.55
8.2
6.3
1.4
1.5
mmol/l
0.23
415
2116
276
1187
2.47
39.46
4.9
3.6
23.6
24.0
mmol/l
1.46
255
1047
451
2388
2.06
38.87
5.6
6.7
11.8
12.2
mmol/l
0.50
421
2238
1461
11112
1.64
36.30
8.2
6.1
10.8
13.1
umol/l
7.11
1406
10518
1291
9592
1.63
34.67
6.2
3.9
0.0
0.0
estimate
0.50
267
1779
1275
9477
1.62
33.95
6.1
3.9
0.0
0.0
estimate
0.00
274
1836
544
3203
1.86
33.94
5.6
5.7
1.0
1.0
mmol/l
0.16
511
2933
1267
9432
1.62
33.32
8.0
5.2
0.0
0.0
estimate
0.00
272
1852
306
1486
2.19
32.79
5.8
3.0
0.8
0.3
e6/l
2.07
301
1462
1294
9716
1.61
32.61
5.8
4.8
32.5
34.1
g/l
14.31
1212
8885
314
1569
2.12
31.22
10.2
8.3
0.5
0.7
%
7.17
306
1556
514
3048
1.84
31.09
8.5
6.6
5.1
5.0
kpa
0.40
488
2870
514
3048
1.84
31.09
8.5
6.6
13.0
11.5
kpa
9.30
483
2872
314
1573
2.12
31.01
10.1
8.2
1.1
1.3
%
3.78
306
1561
282
1357
2.20
30.85
10.5
9.3
—
—
—
0
0
513
3049
1.83
30.77
8.5
6.6
-0.2
1.1
mmol/l
7.92
411
2302
1605
12892
1.56
28.77
6.9
5.0
7.0
7.0
mmol/l
0.17
1542
12172
283
1403
2.13
28.64
10.4
8.3
23.4
24.2
mmol/l
4.04
267
1284
423
2441
1.86
27.67
9.5
7.4
115.1
120.7
g/l
8.00
414
2352
1413
11209
1.52
25.55
10.8
8.3
4.8
4.5
e9/l
4.02
1272
9692
1297
10107
1.52
25.51
7.8
6.1
1.2
1.2
mmol/l
2.04
1185
9045
323
1750
1.95
25.50
1.6
1.6
—
—
—
0
0
1305
10198
1.51
25.23
10.5
12.2
1.3
1.4
inr
5.22
309
2796
1385
11117
1.48
22.54
8.4
7.0
1.2
1.2
mmol/l
1.63
1172
9247
158
689
2.37
21.74
3.5
3.0
8.4
7.6
kpa
6.83
150
635
891
6609
1.51
21.11
3.4
2.5
62.2
59.1
u/l
0.43
843
6079
347
2042
1.80
20.98
3.7
3.0
4.2
4.4
kpa
1.48
335
1957
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
208
1041
2.08
20.41
2.6
2.6
0.4
0.3
u/ml
0.39
104
607
252
1355
1.94
20.21
5.1
3.5
24.6
24.9
mmol/l
0.56
247
1316
281
1584
1.86
19.50
4.6
3.2
124.5
127.0
g/l
0.92
276
1551
276
1562
1.85
18.90
1.6
1.5
—
—
—
0
0
165
798
2.13
17.71
4.2
3.2
23.3
24.8
mmol/l
4.49
153
689
931
7181
1.44
17.30
4.5
3.3
2.3
2.3
mmol/l
1.15
795
6082
1790
15544
1.41
16.45
10.4
7.6
88.2
83.0
u/l
2.37
1712
14493
946
7370
1.42
16.45
7.1
4.2
—
—
—
0
0
1151
9343
1.39
15.52
6.1
5.8
23.1
24.8
%
5.73
1082
8573
327
2054
1.67
15.47
2.4
2.1
0.2
0.2
g/l
1.45
303
1874
58
181
3.25
15.18
1.3
1.3
—
—
—
0
0
447
3086
1.53
14.15
3.6
3.8
231.9
245.3
u/l
1.15
424
2888
1120
9183
1.36
13.66
6.0
5.6
61.2
59.5
%
4.16
1055
8493
84
350
2.44
12.88
5.3
6.2
12.5
12.3
mg/l
0.13
77
319
209
1222
1.77
12.79
1.8
1.8
3.1
2.8
ug/l
0.12
180
1053
63
238
2.68
11.83
2.6
2.0
4.5
1.8
u/field
0.81
27
85
698
5405
1.39
11.82
7.2
4.2
0.0
0.0
estimate
0.24
223
1691
244
1565
1.61
10.55
4.1
2.1
416.9
375.2
nmol/l
2.39
231
1410
42
138
3.07
10.20
2.5
1.8
5.7
2.5
u/field
1.38
28
95
193
1190
1.67
9.77
3.2
2.5
0.7
0.7
%
0.56
186
1147
511
3866
1.39
9.75
2.3
1.9
29.8
30.5
s
2.47
499
3742
2039
18702
1.32
9.61
28.3
18.9
37.9
29.7
mg/l
19.89
1881
15668
59
250
2.39
8.83
2.6
2.8
—
—
—
0
0
35
113
3.12
8.79
1.3
1.3
39.7
22.8
iu/l
1.69
30
92
503
3877
1.36
8.46
2.8
2.5
11.2
11.9
umol/l
1.40
465
3551
774
6348
1.30
8.45
2.4
2.2
3.2
3.1
mg/l
0.24
667
5322
63
287
2.22
8.01
1.2
1.3
15.6
8.5
u/l
3.29
51
227
107
595
1.83
7.83
3.0
2.6
17.1
15.7
%
2.99
77
313
241
1651
1.50
7.79
4.6
3.0
57.0
58.7
ml/min/173m2
0.33
128
723
449
3442
1.36
7.78
2.8
2.6
20.5
21.8
%
1.14
378
2901
344
2533
1.41
7.60
3.2
3.9
52.5
27.3
ug/l
0.32
289
2139
57
257
2.24
7.46
1.2
1.4
—
—
—
0
0
42
165
2.57
7.42
1.2
1.4
—
—
—
0
0
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
57
259
2.22
7.33
1.2
1.4
—
—
—
0
0
466
3625
1.34
7.31
2.8
2.5
2.2
2.2
g/l
0.06
427
3317
709
5849
1.28
7.23
3.6
3.1
35.0
37.2
u/l
0.37
672
5531
56
255
2.22
7.17
1.2
1.4
—
—
—
0
0
42
168
2.52
7.17
1.2
1.4
—
—
—
0
0
33
119
2.79
6.90
1.1
1.4
—
—
—
0
0
33
119
2.79
6.90
1.1
1.5
—
—
—
0
0
254
1811
1.44
6.72
2.6
2.3
39.5
37.0
u/l
0.26
215
1520
1093
9544
1.24
6.70
2.4
2.2
91.0
90.7
pmol/l
0.08
689
5220
80
431
1.88
6.53
1.2
1.4
—
—
—
0
0
914
7891
1.23
6.10
3.1
2.8
172.2
181.6
ug/l
0.53
841
7062
169
1138
1.52
5.98
2.2
1.9
—
—
—
0
0
150
995
1.54
5.70
3.1
2.7
—
—
—
0
0
101
609
1.68
5.68
2.4
2.2
129.7
127.7
g/l
0.31
79
453
233
1691
1.41
5.61
8.3
6.4
23.9
24.4
mmol/l
0.90
220
1582
531
4362
1.27
5.45
2.0
1.9
—
—
—
0
0
22
73
3.03
5.37
2.0
2.9
—
—
—
0
0
522
4314
1.26
5.06
3.7
3.1
2.5
2.5
mmol/l
4.58
448
3714
226
1666
1.39
4.99
1.8
1.7
—
—
—
0
0
75
434
1.75
4.94
2.2
3.9
1.5
1.5
%
0.03
53
314
122
800
1.55
4.93
1.3
1.3
—
—
—
0
0
152
1046
1.48
4.89
2.1
1.8
—
—
—
0
0
564
4720
1.24
4.88
4.4
4.3
277.3
623.9
ng/l
1.01
493
4202
522
4337
1.25
4.82
8.0
4.3
1.0
1.0
kg/l
0.38
105
689
1837
17189
1.19
4.74
28.4
18.1
66.2
70.4
ml/min/173m2
14.66
1662
14320
2085
19745
1.21
4.67
34.6
22.6
139.2
139.6
mmol/l
7.25
2040
19132
2087
19775
1.21
4.61
34.7
22.8
4.1
4.0
mmol/l
10.92
2041
19130
156
1099
1.44
4.47
5.9
5.1
1.6
1.6
%
0.06
151
1030
1693
15772
1.18
4.44
28.9
20.3
35.9
38.3
%
9.92
982
9256
154
1084
1.44
4.44
6.0
5.2
0.9
0.9
%
0.41
149
1015
371
4554
0.79
4.42
1.6
1.6
1.4
1.3
mmol/l
1.26
312
3734
483
4020
1.24
4.37
29.8
31.2
1.4
1.6
inr
0.71
70
564
38
185
2.07
4.25
1.2
1.2
45.2
62.2
u/l
1.35
26
122
54
298
1.83
4.21
1.2
1.3
—
—
—
0
0
1024
9209
1.17
4.02
4.7
4.5
54.8
84.5
ng/l
0.83
864
7421
114
779
1.48
3.87
4.6
3.7
4.1
4.0
mmol/l
1.48
105
706
915
8186
1.17
3.78
3.1
3.3
2502.7
2164.5
ng/l
0.85
800
7180
187
1408
1.35
3.68
1.5
1.7
1.8
1.5
g/l
3.15
163
1197
219
1690
1.32
3.65
3.8
3.9
102.9
103.6
ng/l
0.03
184
1438
48
269
1.80
3.61
2.4
4.0
64.1
58.8
%
0.84
30
159
50
285
1.77
3.56
1.3
1.7
2.6
4.5
iu/l
—
9
83
2100
20068
1.18
3.53
41.2
27.3
241.6
229.4
e9/l
11.65
2041
19351
2100
20071
1.17
3.51
41.2
27.3
4.2
4.4
e12/l
29.96
2029
19256
2100
20074
1.17
3.49
41.5
27.5
126.2
133.1
g/l
57.83
2052
19571
2100
20076
1.17
3.48
41.2
27.3
7.7
7.1
e9/l
14.01
2032
19260
97
663
1.48
3.33
2.0
2.3
195.6
107.4
ug/min
0.65
57
396
65
411
1.59
3.19
1.1
1.3
—
—
—
0
0
14
50
2.81
3.08
1.4
1.3
—
—
—
0
0
1169
10834
1.13
2.74
3.6
3.2
66.1
60.2
u/l
0.77
1062
9792
76
520
1.47
2.66
2.0
2.3
32.0
33.5
umol/l
0.22
64
423
16
69
2.33
2.48
1.3
2.0
1822.1
814.2
e6/l
—
10
55
15
63
2.39
2.46
1.3
1.7
1914.1
35502.5
e6/l
—
7
39
122
924
1.33
2.41
2.4
2.2
869.6
544.9
ug/l
0.53
117
878
10
34
2.95
2.41
3.7
3.0
0.1
0.3
u/field
—
10
34
2020
19441
1.13
2.40
13.4
11.2
24.6
25.5
u/l
1.19
1940
18467
77
542
1.43
2.37
2.9
2.7
2.1
1.8
mg/l
0.97
68
465
34
198
1.73
2.35
1.0
1.1
—
—
—
0
0
117
891
1.33
2.25
2.6
3.1
816.5
5792.3
u/ml
0.89
104
757
54
358
1.52
2.25
1.1
1.1
—
—
—
0
0
77
548
1.42
2.24
1.5
1.5
231.0
257.3
ug/g
0.56
46
347
20
101
1.99
2.15
5.5
5.7
17.4
26.4
u/ml
—
7
27
280
2382
1.19
2.08
2.9
2.7
11.2
10.3
umol/l
0.16
236
2111
49
325
1.52
2.06
2.5
2.2
42.1
24.1
mg/l
—
10
79
344
2984
1.17
2.04
1.9
1.8
—
—
—
0
0
19
97
1.96
2.00
1.2
1.1
13.9
37.4
u/l
2.22
14
70
19
97
1.96
2.00
1.2
1.1
79.4
102.8
u/l
0.64
14
72
1488
14157
1.11
1.97
4.3
4.1
18.6
14.9
mm/h
10.28
1347
12838
86
640
1.35
1.96
1.6
1.5
—
—
—
0
0
287
2474
1.18
1.86
2.3
2.5
4.6
7.2
ug/l
3.71
236
2109
45
302
1.50
1.82
4.3
3.4
—
—
—
0
0
341
2988
1.16
1.80
1.9
1.8
—
—
—
0
0
266
2287
1.18
1.78
2.2
2.5
65.5
65.9
g/l
0.31
236
2051
36
232
1.56
1.76
1.4
1.5
—
—
—
0
0
92
712
1.30
1.65
1.4
1.5
—
—
—
0
0
94
731
1.30
1.63
3.7
3.3
4.3
4.3
pmol/l
0.08
87
621
1691
17526
0.91
1.61
4.4
4.8
4.2
4.2
mmol/l
0.71
1498
15757
595
5451
1.12
1.59
1.8
1.8
1109.7
1162.5
nmol/l
0.71
439
4057
85
655
1.31
1.59
1.2
1.1
109.8
128.0
iu/ml
0.13
17
224
742
6881
1.11
1.57
2.1
2.2
206.7
246.8
u/l
0.89
695
6399
1672
17326
0.92
1.56
4.3
4.7
1.3
1.4
mmol/l
1.84
1472
15415
17
92
1.85
1.56
1.2
1.1
1.0
1.3
u/ml
—
9
36
979
10355
0.92
1.43
4.2
4.8
21.1
22.2
%
1.66
484
5613
632
5842
1.10
1.43
2.9
3.0
7140.6
7030.3
umol/l
0.02
543
4907
23
141
1.64
1.41
2.2
2.4
—
—
—
0
0
1349
12908
1.09
1.40
4.8
5.6
3.1
4.9
ug/l
1.85
1124
11361
1628
16826
0.92
1.31
4.0
4.3
1.4
1.3
mmol/l
6.17
1414
14831
196
2260
0.86
1.30
1.2
1.2
47.7
12.8
u/ml
0.60
55
772
560
5180
1.10
1.25
1.7
1.8
29273926.5
18945257.5
pmol/l
0.14
468
4170
46
339
1.36
1.21
1.1
1.1
—
—
—
0
0
282
2518
1.13
1.20
5.6
4.0
—
—
—
0
0
287
2568
1.13
1.18
4.3
4.8
32.6
33.0
%
0.20
188
1656
1763
18123
0.93
1.16
4.9
5.4
2.4
2.4
mmol/l
1.29
1554
16189
32
225
1.43
1.12
1.4
1.7
348.3
280.8
mu/l
0.74
32
211
215
1898
1.14
1.10
4.7
4.0
1.2
1.2
mmol/l
0.28
196
1656
7
139
0.50
1.09
1.1
1.0
—
—
—
0
0
1507
14577
1.07
1.08
34.0
22.7
14.3
14.0
%
10.78
1471
14170
54
693
0.77
1.08
2.9
3.1
0.8
0.8
nmol/l
0.45
37
518
7
33
2.12
1.05
2.6
1.6
198.7
196.4
ng/l
—
7
33
869
8259
1.07
1.02
2.3
2.2
—
—
—
0
0
32
230
1.40
1.01
1.9
2.2
753.8
639.7
ml
0.60
17
137
19
123
1.55
0.99
2.2
2.0
—
—
—
0
0
60
477
1.26
0.97
1.5
1.6
—
—
—
0
0
7
36
1.95
0.97
12.1
17.5
1063.3
1375.9
nmol/l
—
7
36
18
118
1.53
0.90
1.4
1.6
4.3
9.2
u/l
—
6
60
48
376
1.28
0.89
3.0
3.8
62.7
59.7
%
0.69
48
376
30
219
1.37
0.89
1.6
1.4
—
—
—
0
0
214
2379
0.89
0.89
1.2
1.2
38.2
39.6
iu/ml
0.04
68
720
433
4030
1.09
0.88
1.7
1.7
2.0
1.6
mg/l
1.08
368
3210
6
31
1.94
0.84
1.8
1.4
—
—
—
0
0
163
1834
0.88
0.84
1.9
2.1
10.7
11.8
nmol/l
0.88
133
1553
96
818
1.18
0.83
1.6
2.3
36.6
36.8
g/l
0.08
76
686
72
598
1.21
0.82
1.7
1.3
—
—
—
0
0
72
598
1.21
0.82
1.7
1.3
—
—
—
0
0
109
940
1.17
0.82
2.4
3.3
71.4
62.7
mg/l
0.24
89
761
267
2917
0.91
0.82
1.2
1.2
3.5
1.9
u/ml
0.37
55
717
6
32
1.88
0.81
8.7
12.9
5.3
5.9
mmol/l
—
6
32
6
32
1.88
0.81
1.2
1.2
—
—
—
0
0
85
720
1.19
0.80
1.6
1.7
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
6
33
1.82
0.79
1.5
1.2
—
—
—
0
0
11
175
0.63
0.78
1.0
1.5
—
1640.0
—
0
6
5
100
0.50
0.77
1.2
1.0
225.8
290.1
mg/l
—
5
86
22
157
1.40
0.76
1.1
1.2
270.8
128.2
miu/ml
—
5
35
6
34
1.77
0.76
1.7
2.4
—
—
—
0
0
9
53
1.70
0.75
2.2
2.5
—
—
—
0
0
108
939
1.16
0.75
2.5
3.3
44.4
68.1
mg/l
0.85
88
767
696
7291
0.94
0.74
2.9
3.3
0.8
0.8
ug/l
0.54
480
5306
5
24
2.08
0.74
1.2
1.9
6.1
2.1
ug/l
—
5
9
16
108
1.48
0.73
1.8
2.2
17.8
16.2
%
—
6
44
121
1065
1.14
0.72
2.0
2.4
4.0
3.8
g/l
0.64
82
747
121
1067
1.14
0.70
2.0
2.4
—
—
—
0
0
111
973
1.15
0.70
2.1
2.5
3.2
3.1
g/l
0.40
83
760
114
1002
1.14
0.69
2.0
2.4
9.8
10.5
g/l
0.91
91
841
121
1068
1.14
0.69
2.0
2.4
7.4
7.4
g/l
0.07
82
771
60
500
1.20
0.69
1.3
1.2
—
—
—
0
0
365
3413
1.08
0.69
2.2
2.3
1.9
1.7
%
1.74
312
2969
756
7245
1.06
0.69
3.9
4.0
16.1
10.2
mg/mmol
2.55
544
4806
1771
18050
0.95
0.67
5.1
5.2
6.3
6.2
mmol/l
1.42
1571
15859
63
535
1.18
0.61
3.6
3.6
34.4
32.4
mg/l
0.17
38
359
8
51
1.57
0.60
3.0
1.9
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
33
263
1.26
0.59
1.8
1.5
64.8
66.9
%
0.13
23
170
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
56
660
0.85
0.59
2.0
1.9
—
—
—
0
0
22
288
0.76
0.59
1.8
1.6
—
—
—
0
0
7
112
0.62
0.58
1.4
1.5
13.7
16.3
umol/l
—
7
102
14
98
1.43
0.56
1.0
1.2
—
—
—
0
0
5
90
0.55
0.55
1.2
1.2
—
—
—
0
0
27
212
1.28
0.55
1.3
1.6
—
—
—
0
0
713
6866
1.05
0.55
3.1
3.2
7.0
7.6
mmol/l
4.42
575
5585
58
496
1.17
0.54
1.3
1.2
—
—
—
0
0
9
60
1.50
0.54
1.0
1.2
—
—
—
0
0
44
367
1.20
0.54
1.1
1.4
—
—
—
0
0
14
99
1.42
0.54
2.4
2.0
0.3
0.2
e9/l
0.76
14
88
48
404
1.19
0.54
1.1
1.4
—
—
—
0
0
19
143
1.33
0.52
1.2
1.2
—
—
—
0
0
15
109
1.38
0.50
1.9
2.3
—
—
—
0
0
57
491
1.16
0.50
2.6
3.3
144.3
1191.8
u/ml
1.16
51
456
17
224
0.76
0.49
1.5
1.6
—
—
—
0
0
70
615
1.14
0.48
1.5
1.4
—
—
—
0
0
291
2746
1.07
0.47
13.0
8.7
—
—
—
0
0
5
82
0.61
0.45
3.2
1.9
18.8
45.0
u/l
—
5
75
83
742
1.12
0.45
1.8
1.7
33.9
37.1
u/l
0.61
69
619
52
450
1.16
0.44
1.1
1.2
25.1
49.0
u/l
1.79
44
386
41
349
1.18
0.43
4.0
7.6
7.8
7.7
mmol/l
0.09
36
284
14
185
0.76
0.43
1.1
1.2
7.3
5.3
u/ml
—
6
91
98
888
1.11
0.42
1.8
2.6
0.7
1.3
g/l
1.00
79
743
12
162
0.74
0.42
1.0
1.0
582.5
629.0
ng/l
—
6
96
12
162
0.74
0.42
1.0
1.0
44.7
41.8
ng/l
—
7
98
12
162
0.74
0.42
1.0
1.0
372.7
298.5
ng/l
—
7
100
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
27
222
1.22
0.41
1.3
1.6
—
—
—
0
0
1272
12959
0.97
0.40
3.6
3.4
15.1
15.1
pmol/l
0.05
1116
11333
0
18
0.00
0.40
0.0
6.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
12
88
1.36
0.40
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
102
0.69
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.8
2.3
—
—
—
0
0
52
456
1.14
0.39
1.2
1.3
0.2
0.2
g/l
0.17
43
433
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
10
137
0.73
0.39
1.1
1.1
2.7
2.1
mmol/l
—
10
123
147
1366
1.08
0.38
2.2
2.7
10.3
10.9
g/l
1.02
135
1236
19
151
1.26
0.38
2.2
2.2
11.8
79.7
ug/min
—
5
39
602
5835
1.04
0.37
1.6
1.6
18.9
19.2
nmol/l
0.17
524
4950
6
44
1.36
0.34
2.0
1.3
8.0
10.1
ug/l
—
6
44
40
349
1.15
0.33
1.8
1.6
—
—
—
0
0
15
188
0.80
0.33
1.1
1.2
1.8
3.4
u/ml
—
6
70
1726
17457
0.97
0.32
6.7
6.8
42.6
41.6
mmol/mol
2.46
1552
15729
7
100
0.70
0.30
1.0
1.0
—
—
—
0
0
49
438
1.12
0.30
1.3
1.5
1073.4
1900.8
e6/l
1.41
34
311
21
175
1.20
0.30
3.6
3.5
—
—
—
0
0
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
47
525
0.89
0.29
1.1
1.1
—
1.9
—
0
7
10
130
0.77
0.29
1.0
1.2
—
—
—
0
0
30
260
1.16
0.28
1.2
1.3
122.8
125.9
u/ml
—
5
45
56
509
1.10
0.27
1.6
1.6
1.0
25.4
iu/ml
1.15
19
129
45
404
1.12
0.26
1.3
1.4
16883.7
79840.5
e6/l
2.57
30
242
65
596
1.09
0.26
1.3
1.2
—
—
—
0
0
18
150
1.20
0.26
1.2
1.1
—
59.0
—
0
11
27
310
0.87
0.26
1.1
1.1
—
—
—
0
0
42
377
1.12
0.25
1.2
1.2
5.0
3.9
u/ml
—
6
51
52
473
1.10
0.25
1.2
1.3
1.1
1.1
g/l
0.11
44
447
77
714
1.08
0.25
1.7
2.5
0.0
0.0
g/l
0.00
70
647
6
83
0.72
0.24
1.0
1.2
—
—
—
0
0
244
2530
0.96
0.23
2.9
3.1
254.3
293.7
ng/l
0.79
222
2319
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
30
336
0.89
0.21
1.0
1.1
—
15.9
—
0
18
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
1631
16451
0.98
0.21
4.5
4.3
2.0
2.1
mu/l
2.69
1449
14480
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
38
418
0.91
0.20
1.4
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
16
187
0.85
0.20
2.0
1.6
—
—
—
0
0
55
593
0.93
0.20
1.5
1.5
—
—
—
0
0
6
51
1.18
0.19
1.5
2.1
21.8
31.8
%
—
6
45
11
90
1.22
0.19
1.1
1.0
—
—
—
0
0
23
203
1.13
0.19
1.0
1.3
264.1
252.1
pmol/l
0.06
15
156
24
213
1.13
0.18
1.7
1.3
20090.4
156750.4
e6/l
1.73
19
149
48
518
0.93
0.18
1.3
1.2
0.3
1.2
u/ml
—
5
48
14
119
1.18
0.17
2.1
2.0
323.8
608.6
e6/l
—
8
48
30
272
1.10
0.17
1.3
1.3
9.4
15.1
u/l
1.94
30
248
82
777
1.06
0.17
1.7
2.4
0.0
0.1
g/l
2.07
75
696
5
70
0.71
0.16
1.2
1.1
—
—
—
0
0
149
1545
0.96
0.16
2.3
2.2
178.7
179.6
ug/g
0.01
122
1199
77
730
1.06
0.16
1.7
2.4
0.0
0.0
g/l
0.79
70
651
13
151
0.86
0.15
1.7
1.6
—
—
—
0
0
73
770
0.95
0.15
1.2
1.3
517.8
269.6
u/ml
0.60
68
701
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
11
93
1.18
0.14
1.2
1.2
—
—
—
0
0
40
372
1.08
0.14
1.4
1.4
—
—
—
0
0
13
149
0.87
0.13
1.7
1.6
—
—
—
0
0
142
1466
0.97
0.13
1.2
1.2
—
—
—
0
0
52
550
0.94
0.13
1.1
1.0
—
—
—
0
0
10
116
0.86
0.12
1.2
1.3
—
—
—
0
0
14
124
1.13
0.11
1.1
1.2
13.1
11.8
mmol/l
—
5
41
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
34
360
0.94
0.09
1.3
1.3
—
—
—
0
0
12
134
0.89
0.08
1.0
1.0
—
—
—
0
0
36
341
1.06
0.08
1.6
1.5
—
—
—
0
0
6
57
1.05
0.08
1.3
1.2
—
—
—
0
0
153
1498
1.02
0.08
1.6
1.7
1.7
1.7
%
0.20
125
1241
23
246
0.93
0.08
1.2
1.2
201.4
306.7
u/ml
1.34
12
137
14
127
1.10
0.07
1.1
1.2
—
—
—
0
0
16
174
0.92
0.07
1.7
1.5
—
—
—
0
0
8
74
1.08
0.07
1.1
1.7
—
—
—
0
0
8
92
0.87
0.06
2.0
1.2
—
—
—
0
0
35
364
0.96
0.05
1.3
1.3
22.5
33.5
e6/l
0.24
24
290
35
364
0.96
0.05
1.5
1.4
1347.1
814.7
e6/l
0.24
27
301
37
384
0.96
0.05
5.8
4.7
1700.4
5182.3
iu/ml
—
7
50
16
150
1.07
0.04
1.0
1.1
—
—
—
0
0
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
34
329
1.03
0.03
1.4
1.5
—
—
—
0
0
15
141
1.06
0.03
1.6
3.1
—
—
—
0
0
17
161
1.06
0.03
1.1
1.1
—
—
—
0
0
10
92
1.09
0.03
1.3
1.6
—
—
—
0
0
742
7396
1.00
0.03
2.1
2.1
77.6
78.0
nmol/l
0.14
653
6346
42
411
1.02
0.02
1.6
1.5
—
—
—
0
0
10
93
1.08
0.02
1.4
1.6
—
—
—
0
0
10
93
1.08
0.02
1.4
1.6
—
—
—
0
0
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
63
639
0.99
0.02
1.4
1.4
—
—
—
0
0
34
348
0.98
0.01
1.4
1.3
325.9
431.6
u/l
0.36
34
327
55
558
0.99
0.01
1.5
1.6
—
—
—
0
0
42
427
0.98
0.01
1.5
1.6
—
—
—
0
0
54
547
0.99
0.01
1.7
1.6
32860.0
15804.5
e6/l
0.79
43
381
10
94
1.06
0.01
1.4
1.4
—
—
—
0
0
12
114
1.05
0.00
1.1
1.0
—
—
—
0
0
14
134
1.04
0.00
1.0
1.4
—
—
—
0
0
14
134
1.04
0.00
1.0
1.4
—
—
—
0
0
34
346
0.98
0.00
1.6
1.6
—
—
—
0
0
23
231
1.00
0.00
1.1
1.1
—
—
—
0
0
20
201
0.99
0.00
2.1
1.4
15.1
20.7
%
0.80
15
126
31
309
1.00
0.00
1.2
1.3
—
18.8
—
0
8
27
269
1.00
0.00
1.2
1.2
—
—
—
0
0
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
10
96
1.04
0.00
1.4
1.6
—
—
—
0
0
26
262
0.99
0.00
3.8
3.9
366.4
328.5
umol/l
0.81
20
222
48
475
1.01
0.00
1.5
1.6
—
—
—
0
0
30
297
1.01
0.00
1.5
1.3
—
—
—
0
0
17
174
0.98
0.00
1.2
1.4
—
192.8
—
0
25
17
174
0.98
0.00
1.5
1.3
—
—
—
0
0
10
99
1.01
0.00
1.2
1.2
203.9
396.4
u/l
—
10
91
13
125
1.04
0.00
1.5
2.1
—
—
—
0
0
25
251
1.00
0.00
1.5
1.4
13.2
13.5
u/l
0.09
25
233
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
3.8
—
29.8
—
0
5
8
81
0.99
0.00
2.3
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
4.5
—
0
8
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
9
92
0.98
0.00
2.7
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
0.00
2.7
2.1
—
—
—
0
0
5
57
0.88
0.00
4.2
2.8
13.1
14.7
ml/dl
—
5
52
7
76
0.92
0.00
1.1
1.2
84.3
247.1
iu/ml
—
7
76
0
8
0.00
0.00
0.0
1.1
—
31.3
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
1.0
1.2
—
58.3
%
—
0
10
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BLADDER – Malignant neoplasm of bladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).